Link Says Versant’s Eyes Will Be On Ophthalmology

August 12, 2014
SUBSCRIBE ON iTUNES

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 002″]

Bill Link explains why ophthalmology will continue to be a pillar for Versant’s new fund. He also talks about the impact of industry consolidation, the Sunshine Act, and he offers helpful advice to entrepreneurs and physicians looking to turn inspiration into innovation.

Podcast Guest

William-Link

William J. Link, PhD

Bill was Founder, Chairman and CEO of Chiron Vision, sold in 1997. Bill founded and served as President of American Medical Optics (AMO), sold in 1986. Bill served on the Board of AMO’s successor company, Advanced Medical Optics (acquired by Abbott in 2009).

View Full Profile

Do You Have

A STORY TO TELL?

If you’d like to be considered as a guest on a future episode of the OIS podcast, please complete the application today.

Meet Our Hosts

Ehsan Sadri
ehsan sadri
Firas Rahhal
FirasRahhal
Paul Karpecki
Paul Karpecki
Subscribe

ON iTUNES

Don't miss an episode. Join the conversation by visiting our podcast channel on iTunes today and subscribe. It's fast and free!

STAY UP TO DATE WITH OIS

Get the Latest News, Podcasts and Videos.

SUBSCRIBE TODAY